Share Email Print

Proceedings Paper

Fluorescence of prostate-specific antigen as measured with a portable 1D scanner
Author(s): Byeong C. Kim; Jin H. Jeong; Dong S. Jeong; Young M. Kim; Sang W. Oh; Eui Y. Choi; Jae H. Kim; Kie Bong Nahm
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Prostate-specific antigen (PSA) is an androgen-dependent glycoprotein protease (M.W. 33 kDa) and a member of kallikrein super-family of serine protease, and has chymotrypsin-like enzymatic activity. It is synthesized by the prostate epithelial cells and found in the prostate gland and seminal plasma as a major protein. It is widely used as a clinical marker for diagnosis, screening, monitoring and prognosis of prostate cancer. In normal male adults, the concentration of PSA in the blood is below 4 ng/ml and this value increases in patients with the prostate cancer or the benign prostatic hyperplasia (BPH) due to its leakage into the circulatory system. As such, systematic monitoring of the PSA level in the blood can provide critical information about the progress of the prostatic disease. We have developed a compact integral system that can quantitatively measure the concentration of total PSA in human blood. This system utilizes the fluorescence emitted from the dye molecules attached to PSA molecules after appropriate immunoassay-based processing. Developed for the purpose of providing an affordable means of fast point-of-care testing of the prostate cancer, this system proved to be able to detect the presence of the PSA at the level of 0.18 ng/ml in less than 12 minutes, with the actual measurement taking less than 2 minutes. The design concept for this system is presented together with the result for a few representative samples.

Paper Details

Date Published: 18 January 2005
PDF: 7 pages
Proc. SPIE 5630, Optics in Health Care and Biomedical Optics: Diagnostics and Treatment II, (18 January 2005); doi: 10.1117/12.577226
Show Author Affiliations
Byeong C. Kim, Biomed Photonics Inc. (South Korea)
Jin H. Jeong, Hallym Univ. (South Korea)
Dong S. Jeong, Hallym Univ. (South Korea)
Boditech Med Inc. (South Korea)
Young M. Kim, Boditech Med Inc. (South Korea)
Sang W. Oh, Boditech Med Inc. (South Korea)
Eui Y. Choi, Hallym Univ. (South Korea)
Boditech Med. Inc. (South Korea)
Jae H. Kim, Biomed Photonics, Inc. (South Korea)
Hanyang Univ. (South Korea)
Kie Bong Nahm, Hallym Univ. (South Korea)

Published in SPIE Proceedings Vol. 5630:
Optics in Health Care and Biomedical Optics: Diagnostics and Treatment II
Britton Chance; Mingzhe Chen; Arthur E. T. Chiou; Qingming Luo, Editor(s)

© SPIE. Terms of Use
Back to Top